Brief: Bright Minds Biosciences Announces Application To List On Nasdaq
16/06/2021 12:48
June 16 (Reuters) - Bright Minds Biosciences Inc DRUG.CD :
* BRIGHT MINDS BIOSCIENCES ANNOUNCES APPLICATION TO LIST ON
NASDAQ
* BRIGHT MINDS BIOSCIENCES INC - COMPANY HAS RESERVED RIGHT
TO
TRADE UNDER SYMBOL "DRUG."
Source text for Eikon: ID:nGNX2h8Kkb
Further company coverage: DRUG.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bright Minds Biosciences
See all newsBright Minds Biosciences slips after increased $175 mln stock sale
Brief: Bright Minds Biosciences Announces Pricing Of Upsized US$175 Million Public Offering Of Common Stock At $90.00 Per Share
Bright Minds Biosciences falls after $100 mln equity offering launched
Brief: Bright Minds To Announce Topline Results For BMB-101 Phase 2 Trial In On Jan 6
Brief: Bright Minds Biosciences Files For Offering Of Up To 1.6 Million Common Shares By The Selling Securityholders